Andrew ElBardissi

Andrew ElBardissi, MD

Partner, Deerfield Management
Board Director

Dr. Andrew ElBardissi has been a Partner on the Medical Technologies team at Deerfield Management since 2017. Prior to Deerfield, Dr. ElBardissi was a Principal at Longitude Capital, where he focused on investments in medtech and biotechnology. Before that, he was an Associate in JPMorgan Chase’s healthcare investment banking practice. Dr. ElBardissi received his residency training in general surgery at Harvard Medical School’s Brigham and Women’s Hospital and in cardiothoracic surgery at Stanford University. He has been independently funded by the National Institutes of Health and the Agency for Healthcare Research and Quality, has authored more than 30 publications in leading peer-reviewed scientific journals, and has presented his research at numerous medical and surgical conferences.

Dr. ElBardissi holds an MD from the Mayo Clinic, an MPH in quantitative methods from Harvard University, an MBA from Harvard Business School, and a BS with honors in biology (Phi Beta Kappa) from the Schreyer Honors College at the Pennsylvania State University.

Bitterroot Bio is a privately held company dedicated to the pursuit of breakthroughs in cardiovascular medicine. We are committed to improving the lives of patients, and we believe that focusing on research and development is the best way to achieve that goal. We do not engage in, support, or advocate on behalf of political, social, environmental, or other causes that are unrelated to our mission.
Scroll to Top